Danaher (NYSE:DHR) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided EPS guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.78. Danaher also updated its FY19 guidance to $4.75-4.80 EPS.
Shares of NYSE:DHR opened at $141.61 on Friday. Danaher has a 52-week low of $94.59 and a 52-week high of $145.50. The company has a market capitalization of $101.38 billion, a PE ratio of 31.33, a P/E/G ratio of 2.56 and a beta of 0.96. The business has a 50 day moving average price of $140.27. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18.
Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The company had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. Danaher had a return on equity of 11.73% and a net margin of 12.22%. Danaher’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.15 earnings per share. As a group, sell-side analysts anticipate that Danaher will post 4.77 EPS for the current fiscal year.
A number of analysts have weighed in on the company. Robert W. Baird upped their target price on Danaher from $131.00 to $148.00 and gave the stock an outperform rating in a report on Friday. Zacks Investment Research lowered GALP ENERGIA SG/ADR from a hold rating to a sell rating in a report on Monday, May 6th. Piper Jaffray Companies upgraded Post from a neutral rating to an overweight rating and upped their target price for the stock from $106.00 to $130.00 in a report on Thursday. Janney Montgomery Scott upped their target price on Danaher from $136.00 to $174.00 and gave the stock a buy rating in a report on Wednesday, April 17th. Finally, Wolfe Research assumed coverage on Waters in a report on Thursday, May 30th. They set an underperform rating for the company. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock currently has an average rating of Buy and an average target price of $139.08.
In other Danaher news, Chairman Mitchell P. Rales acquired 1,900 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was purchased at an average price of $130.78 per share, for a total transaction of $248,482.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Alan G. Spoon sold 1,913 shares of the stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the sale, the director now owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. In the last quarter, insiders have sold 453,448 shares of company stock valued at $59,724,640. Company insiders own 11.40% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Strangles
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.